SCHEMBL6173283

SCHEMBL6173283

CC(C)Nc1cnccc1C(C)C1(C(C)c2ccncc2NC(C)C)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
AR P10275 2/20 0.33
TRPV1 Q8NER1 1/20 0.33
CCR9 P51686 2/20 0.33
NPBWR1 P48145 1/20 0.32
MCHR1 Q99705 1/20 0.32
FLT1 P17948 2/20 0.32
KDR P35968 2/20 0.32
LIPE Q05469 2/20 0.31
KDM4C Q9H3R0 1/20 0.31
MAPT P10636 1/20 0.31
ATP1A1 P05023 1/20 0.31
ATP1B1 P05026 1/20 0.31
ATP1A3 P13637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173454 0.88 CYP2C9 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174307 0.87 CYP2C9 (0.38) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172844 0.87 CYP3A4 (0.40) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173429 0.86 POLB (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6169571 0.86 CYP3A4 (0.35) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6173690 0.85 CYP3A4 (0.41) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174412 0.84 MAPT (0.39) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6174515 0.84 ALDH1A1 (0.45) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172022 0.84 KMT2A (0.36) CYP3A4GAACYP2C9CYP2C19ALDH1A1
SCHEMBL6172977 0.84 CYP3A4 (0.43) CYP3A4GAACYP2C9CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed